Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

427
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
427
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.8K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

960
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
960
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.9K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of ROS1 rearrangement in lung adenocarcinoma stratified by clinicopathologic and radiological features: a retrospective cohort study.

Translational lung cancer research·2026
Same author

[Cessation intention and behavior of e-cigarettes and associated factors among 18-44 Chinese adults: Based on protection motivation theory].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2026
Same author

[Impact of effective health information acquisition on hemophilia-related health literacy among caregivers of underage hemophilia patients].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2026
Same author

A Theory-Based Digital Intervention to Improve Maternal Oral Health Behaviors for Young Children: Quasi-Experimental Study.

JMIR mHealth and uHealth·2026
Same author

What psychosocial factors shape HIV testing willingness among Chinese college students? A cross-sectional survey integrating PLS-SEM and fsQCA.

BMJ public health·2026
Same author

Totally Video-Assisted Thoracoscopic Surgery for Lung Transplantation: A Case Series.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Related Experiment Video

Updated: Nov 17, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.8K

Serum sphingolipid profile in asthma.

Chenglin Guo1, Lina Sun1, Linlin Zhang1

  • 1Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China.

Journal of Leukocyte Biology
|February 18, 2021
PubMed
Summary

Sphingomyelin (SM) levels are decreased in asthma patients, particularly in non-eosinophilic asthma. Lower SM may indicate a protective role and potential therapeutic target for asthma management.

Keywords:
ceramideeosinophilic asthmanoneosinophilic asthmasphingomyelin

More Related Videos

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis
09:09

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis

Published on: April 27, 2021

2.4K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.2K

Related Experiment Videos

Last Updated: Nov 17, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.8K
Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis
09:09

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis

Published on: April 27, 2021

2.4K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.2K

Area of Science:

  • Biochemistry
  • Immunology
  • Metabolomics

Background:

  • Sphingolipid metabolism is crucial for cellular processes and implicated in asthma.
  • The specific role of sphingolipids in asthma pathogenesis and subtypes remains unclear.

Purpose of the Study:

  • To investigate the involvement of sphingolipids in asthma and its distinct subtypes.
  • To identify potential biomarkers and therapeutic targets within sphingolipid pathways.

Main Methods:

  • Serum samples from 51 asthma patients and 9 healthy controls were analyzed.
  • Liquid chromatography-mass spectrometry-based targeted metabolomics was employed to quantify serum sphingolipids.
  • Clinical data and sputum inflammatory markers were correlated with sphingolipid levels.

Main Results:

  • Significantly decreased levels of sphingomyelin (SM) (SM34:2, SM38:1, SM40:1) were observed in asthma patients compared to healthy individuals.
  • Serum SM levels were notably lower in the blood noneosinophilic asthma (bNEA) group versus the blood eosinophilic asthma group.
  • SM levels showed similar decreasing trends in early-onset asthma compared to late-onset asthma.
  • SM 40:1 demonstrated a negative correlation with sputum IL-17A levels.

Conclusions:

  • Sphingomyelin (SM) may act as a protective factor in asthma, particularly in the bNEA subtype.
  • Reduced SM levels are associated with asthma pathogenesis and specific inflammatory markers.
  • SM presents potential as a biomarker and therapeutic target for asthma treatment.